Tom Nolan reviews this week’s research An editorial about D-dimers likens the endlessly talked about blood test to a fine wine. It’s nothing to do with its taste (I find it a bit claggy) or cost, but ...

Trials in AF and acute coronary syndrome were stopped early for futility, but there’s hope for factor XIa inhibitors given ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Early initiation of prophylactic anticoagulation in COVID-19 patients newly admitted to hospital ...

Please provide your email address to receive an email when new articles are posted on . Continuous anticoagulation significantly decreased the rate of deep vein thrombosis and pulmonary embolism.

Oral anticoagulant use was associated with a reduced risk for progression of 60% and a reduced risk for death of 76% in ...

Therapeutic-dose anticoagulation with heparins reduced 28-day mortality compared with prophylactic doses in patients hospitalized with COVID-19. Higher-dose anticoagulation was associated with a ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients hospitalized with COVID-19 who received ...

Our extensive research on the United States Anticoagulation Therapy (2024-2032) offers valuable insights for businesses. This comprehensive report delves into emerging trends, inv ...

Background: Patients taking oral anticoagulant therapy balance the risks of hemorrhage and thromboembolism. We sought to determine the association between anticoagulation intensity and the risk of ...

SAN FRANCISCO, CA—Among patients hospitalized with atrial fibrillation (AF), Black patients are less likely than their white counterparts to be discharged on oral anticoagulation, which appears to be ...